Medical Condition News

RSS

Australian TGA approves Genzyme’s AUBAGIO to treat relapsing forms of multiple sclerosis

Genzyme, a Sanofi company, announced today that the Australian Therapeutic Goods Administration (TGA) has approved AUBAGIO (teriflunomide) 14 mg as a new once-daily, oral treatment indicated for patients with relapsing forms of multiple sclerosis (MS).

21 Nov 2012

Viewpoints: Protecting us from counterfeit medicines; Governors making excuses on insurance exchanges?; Simpson-Bowles and the health law

HHS has made it clear that after federally operated exchanges are up and running, states may eventually take over operations. This seems like wasted effort. States have the information they need to move on insurance exchanges. Governors who care about fiscal responsibility, strong state government and the basic welfare of their residents would do well to get with the program.

21 Nov 2012

FOCUS Clinics Director performs KAMRA Vision surgery on two distinguished ophthalmologists

Dr. David Allamby, Director of FOCUS Clinics, an eye surgery clinic in London, announced that he has performed KAMRA Vision surgery, the proven solution to reading glasses, on two distinguished ophthalmologists.

21 Nov 2012

Rituximab may help patients with aPL-related clinical problems

Rituximab, a drug used to treat cancer and arthritis, may help patients with antiphospholipid antibodies (aPLs) who suffer from aPL-related clinical problems that do not respond to anticoagulation, such as cardiac disease and kidney disease, according to a new study by rheumatology researchers at Hospital for Special Surgery. The study appears online ahead of print, in the journal Arthritis and Rheumatism.

21 Nov 2012

Sectra OneScreen can effectively identify people at high risk for osteoporosis

A research team at the Karolinska Institute in Stockholm has conducted a study that shows how Sectra's online service, Sectra OneScreen, provides an efficient and inexpensive method for early identification of people in the "at-risk group" for osteoporosis. Sectra OneScreen can be combined with routine mammography examinations.

21 Nov 2012

Discovery of DKK1-WNT pathway reveals new drug targets for Alzheimer's

The discovery of the molecular pathway that drives the changes seen in the brains of Alzheimer's patients is reported today, revealing new targets for drug discovery that could be exploited to combat the disease. The study gives the most detailed understanding yet of the complex processes leading to Alzheimer's.

21 Nov 2012

New polymer nanoparticles can generate heat and kill colorectal cancer cells

Researchers at Wake Forest Baptist Medical Center have modified electrically-conductive polymers, commonly used in solar energy applications, to develop revolutionary polymer nanoparticles (PNs) for a medical application. When the nanoparticles are exposed to infrared light, they generate heat that can be used to kill colorectal cancer cells.

21 Nov 2012

BRIGHTs bind to biomarkers of disease and light up to reveal their location

Called BRIGHTs, the tiny probes described in the online issue of Advanced Materials on Nov. 15, bind to biomarkers of disease and, when swept by an infrared laser, light up to reveal their location.

21 Nov 2012

Sweat glands play a key role in providing cells for skin wound recovery

Turns out the same glands that make you sweat are responsible for another job vital to your health: they help heal wounds. Human skin is rich with millions of eccrine sweat glands that help your body cool down after a trip to the gym or on a warm day. These same glands, new University of Michigan Health System research shows, also happen to play a key role in providing cells for recovering skin wounds - such as scrapes, burns and ulcers.

21 Nov 2012

Scientists uncover new role for TLR4 in development of tissue fibrosis or scarring

An international multi-disciplinary research team led by Northwestern Medicine scientists has uncovered a new role for the protein toll-like receptor 4 (TLR4) in the development of tissue fibrosis, or scarring.

21 Nov 2012

Gabrielle's Angel Foundation announces recipients of new collaborative grants for cancer research

Gabrielle's Angel Foundation for Cancer Research today announced grant recipients of its first-ever Collaborative Research grant program. The inaugural awards total $800,000 for two groundbreaking research initiatives that span the medical capitals of New York, Boston and Chicago.

21 Nov 2012

Simple, accurate testing protocol to determine driving fitness in individuals with MS

A simple, accurate testing protocol to determine driving fitness in individuals with multiple sclerosis is the aim of a three-year study at Georgia Health Sciences University.

21 Nov 2012

Viewpoints: Papa John's complaint; Renewed criticism of Justice Roberts; Calif. voters rout food police

If ObamaCare negatively impacts your business, you better not complain about it. That's what Papa John's CEO John Schnatter found out when he announced the health-care law would increase the price of a pizza by up to 14 cents. ... But Papa John's isn't the only restaurant chain to complain that the Affordable Care Act is bad for business.

21 Nov 2012

Health professionals may soon have new method to diagnose Parkinson's

Health professionals may soon have a new method of diagnosing Parkinson's disease, one that is noninvasive and inexpensive, and, in early testing, has proved to be effective more than 90 percent of the time.

21 Nov 2012

WHO DG Chan says media allegations of agency receiving food industry funding to fight NCDs 'wrong'

In a statement released on Monday, WHO Director-General Margaret Chan said "[s]everal recent media articles are creating misinformation and confusion in the public health arena" by "erroneously suggesting that, in working to reduce non-communicable diseases (NCDs) such as cardiovascular diseases, cancers, chronic respiratory diseases and diabetes, WHO receives funding from the food and beverage industry," the U.N. News Centre reports.

21 Nov 2012

Acetylon's ective histone deacetylase inhibitors to be showcased at 54th ASH annual meeting

Acetylon Pharmaceuticals Inc., a leader in targeted epigenetic drug discovery and development for enhanced therapeutic outcomes, today announced that its selective histone deacetylase (HDAC) inhibitors will be featured in five posters and one oral presentation at the 54th Annual Meeting of the American Society of Hematology (ASH), taking place December 8-11, 2012, in Atlanta, Georgia.

21 Nov 2012

Sharp decline in ECT availability and use in the U.S. general hospitals

Electroconvulsive therapy (ECT) is considered the most effective treatment option for patients with severe depression who cannot find symptom relief through antidepressant medications or psychotherapy. In a new study, researchers at Butler Hospital and Bradley Hospital in Rhode Island found a sharp decline in the availability and use of ECT in general hospitals across the U.S.

21 Nov 2012

Fujirebio, Thermo Fisher sign license agreement for broad availability of PCT testing

Thermo Fisher Scientific Inc., the world leader in serving science, today announced it has signed a long-term license agreement with Fujirebio Inc. to make its biomarker assay Procalcitonin (PCT) available on the Lumipulse family of laboratory instruments, using the chemiluminescent enzyme immunoassay (CLEIA) technology.

From Thermo Fisher Scientific Inc. 21 Nov 2012

Musical tones can reset the brain and effectively reduce insomnia

If you are among the 50 percent of Americans who suffer from insomnia, then you have probably tried everything – from warm milk to melatonin pills or prescription medications to induce sleep – with varying degrees of success and side effects. But what if sleep could be achieved not by a substance, but through 'balancing' brain activity?

21 Nov 2012

Young girls can dance their way to better mental health

Young girls can dance their way to better mental health. Symptoms like depression, stress, fatigue, and headaches are alleviated with regular dancing.

21 Nov 2012

Medical Condition News

Australian TGA approves Genzyme’s AUBAGIO to treat relapsing forms of multiple sclerosis

Viewpoints: Protecting us from counterfeit medicines; Governors making excuses on insurance exchanges?; Simpson-Bowles and the health law

FOCUS Clinics Director performs KAMRA Vision surgery on two distinguished ophthalmologists

Rituximab may help patients with aPL-related clinical problems

Sectra OneScreen can effectively identify people at high risk for osteoporosis

Discovery of DKK1-WNT pathway reveals new drug targets for Alzheimer's

New polymer nanoparticles can generate heat and kill colorectal cancer cells

BRIGHTs bind to biomarkers of disease and light up to reveal their location

Sweat glands play a key role in providing cells for skin wound recovery

Scientists uncover new role for TLR4 in development of tissue fibrosis or scarring

Gabrielle's Angel Foundation announces recipients of new collaborative grants for cancer research

Simple, accurate testing protocol to determine driving fitness in individuals with MS

Viewpoints: Papa John's complaint; Renewed criticism of Justice Roberts; Calif. voters rout food police

Health professionals may soon have new method to diagnose Parkinson's

WHO DG Chan says media allegations of agency receiving food industry funding to fight NCDs 'wrong'

Acetylon's ective histone deacetylase inhibitors to be showcased at 54th ASH annual meeting

Sharp decline in ECT availability and use in the U.S. general hospitals

Fujirebio, Thermo Fisher sign license agreement for broad availability of PCT testing

Musical tones can reset the brain and effectively reduce insomnia

Young girls can dance their way to better mental health

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News